The first Sarepta Therapeutics trade was made in Q4 2018.
Since then Cathie Wood bought shares two more times and sold shares on three occasions. The investor completely sold their stake between Q2 2021 and Q3 2021.
Avg closing price
Price range
Sold -504 Thousand shares
Q3 2021
Avg closing price
$77.03
Price range
$65.97
-
$92.48
Sold 72.9% shares (-1.36 Million shares)
Q2 2021
Avg closing price
$75.81
Price range
$69.38
-
$86.75
Increased shares by 665.8% (+1.62 Million shares)
Q1 2021